June 2021 Vol 7 No 3

Emotional Rollercoaster of Cancer
In this heartfelt poem, Priya Kalra writes about riding the challenging waves of emotions after being diagnosed with breast cancer in December 2017.
Conquering the World in My Mom’s Memory
Family Members
Speech-language pathologist Stacey Brill, MS, CCC-SLP, shares her journey by her mom’s side as she battled cancer, and the subsequent care and services she had provided to many patients with cancer, in her mom’s memory.
Rybrevant First FDA-Approved Therapy for Lung Cancer with EGFR Exon 20 Insertion Mutations
FDA Approvals, News & UpdatesLung Cancer
In May 2021, the FDA approved Rybrevant (amivantamab-vmjw), an intravenous antibody that targets mutations in the EGFR and MET pathways, for the treatment of adults with non–small-cell lung cancer and EGFR exon 20 insertion mutations. This is the first drug approved for lung cancer with EGFR exon 20 insertion mutations.
Lumakras First FDA-Approved Drug for Advanced Lung Cancer and KRAS G12C Mutation
FDA Approvals, News & UpdatesLung Cancer
In May 2021, the FDA approved Lumakras (sotorasib), an oral KRAS inhibitor, for the treatment of adults with locally advanced or metastatic non–small-cell lung cancer associated with KRAS G12C mutation. Lumakras is the first drug approved for any cancer associated with any KRAS mutation.
Zynlonta First FDA-Approved CD19-Targeted Therapy for Large B-Cell Lymphoma
FDA Approvals, News & UpdatesLymphoma
In April 2021, the FDA approved Zynlonta (loncastuximab tesirine), the first CD19-directed antibody–drug conjugate, for the treatment of patients with relapsed or refractory large B-cell lymphoma.
Why a Healthy Diet Is So Important for Patients with Gastric Cancer
Nutrition & CancerGastric Cancer
“Because gastric cancers involve the digestive system, following a healthy diet is especially important for patients with this type of cancer,” says Martha Raymond, Founding Executive Director of the GI Cancers Alliance.
Remembering Sheree Marshall Williams, PhD: Racial Disparities in Cancer Care
In Memoriam
Dr. Marshall Williams, Editorial Board member of CONQUER: the patient voice, and public health professional at the Centers for Disease Control and Prevention, highlighted the urgent need to address racial disparities in cancer care.
Sarclisa Now Approved for Relapsed or Refractory Multiple Myeloma
FDA Approvals, News & UpdatesMultiple Myeloma
In March 2021, the FDA approved a new indication for Sarclisa (isatuximab-irfc), in combination with Kyprolis and dexamethasone, for the treatment of adults with relapsed or refractory multiple myeloma.
The Birth of the Cancer Survivorship Movement
Judy Pearson offers a compelling and inspiring historical perspective of the formation of the cancer survivorship movement in the United States, and what this means to cancer survivors today.
Page 1 of 3
Results 1 - 10 of 21

Subscribe to CONQUER: the patient voice

Receive timely cancer news & updates, patient stories, and more.

Race or Ethnicity
Profession or Role
Primary Interest
Other Interests